Displaying drugs 401 - 406 of 406 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Aflibercept | 115000.0 C4318H6788N1164O1304S32 |  | A vascular endothelial growth factor (VEGF) inhibitor used to treat Neovascular (Wet) Age-Related Macular Degeneration (AMD), various types of macular edema and diabetic retinopathy, and metastatic colorectal cancer | Antineovascularisation Agents |
| Aducanumab | 146000.0 | | A monoclonal antibody indicated in the treatment of Alzheimer's disease. | Amyloid Beta-directed Antibodies |
| Adalimumab | 144190.3 C6428H9912N1694O1987S46 |  | A monoclonal anti-tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis. | Tumor necrosis factor alpha (TNF-alpha) inhibitors |
| Abciximab | 145651.1 C6462H9964N1690O2049S48 |  | A monoclonal anti-glycoprotein IIb/IIIa receptor antibody used to prevent thrombosis during percutaneous coronary intervention. | Platelet Aggregation Inhibitors Excl. Heparin |
| Abatacept | 92300.0 C3498H5458N922O1090S32 | | A disease-modifying antirheumatic drug (DMARD) used in the management of rheumatic conditions, such as rheumatoid or psoriatic arthritis, and for the prophylaxis of acute graft-versus-host disease. | Selective Immunosuppressants |
| Abaloparatide | 3961.0 C174H300N56O49 | | A parathyroid hormone-related protein (PTHrP) analog used for the treatment of osteoporosis in patients with a high risk of fracture. | Bone Density Conservation Agents / Parathyroid Hormones and Analogues |
Displaying drugs 401 - 406 of 406 in total